| Jun 17 |
Viking Therapeutics: A Contender In The Growing Obesity Treatment Landscape
|
| Jun 17 |
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
|
| Jun 15 |
2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%
|
| Jun 15 |
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It
|
| Jun 14 |
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
|
| Jun 13 |
Viking Therapeutics, Inc. (VKTX) Stock Declines While Market Improves: Some Information for Investors
|
| Jun 13 |
Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?
|
| Jun 13 |
3 Stocks to Buy if You Want to Turn Your $1,000 into $10,000 Within 2 Years
|
| Jun 11 |
Here’s Why Viking Therapeutics (VKTX) Shares Rose in Q1
|
| Jun 10 |
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
|
